Evaluation of commercial immunodiffusion reagents for detecting serum anti-Paracoccidioides antibodies.
Rev Soc Bras Med Trop
; 57: e007052024, 2024.
Article
de En
| MEDLINE
| ID: mdl-38808801
ABSTRACT
BACKGROUND:
Accurate diagnosis of paracoccidioidomycosis is crucial for improving patient outcomes. Paracoccidioides antibody detection by double immunodiffusion (DID) is a convenient diagnostic tool, but testing performance can vary based on certain factors.METHODS:
We assessed DID performance using a commercially prepared Paracoccidioides reagents (IMMY, USA), involving 40 serum specimens, including 20 from patients with proven paracoccidioidomycosis and 20 from patients without the disease. The DID test demonstrated a sensitivity of 90% (95% CI=68%-99%) and a specificity of 100% (95% CI=83%-100%).CONCLUSIONS:
Our findings suggest that DID using commercial reagents may provide a feasible tool with satisfactory testing performance for anti-Paracoccidioides antibody detection.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Paracoccidioides
/
Blastomycose sud-américaine
/
Sensibilité et spécificité
/
Immunodiffusion
/
Anticorps antifongiques
Limites:
Female
/
Humans
/
Male
Langue:
En
Journal:
Rev Soc Bras Med Trop
Année:
2024
Type de document:
Article
Pays d'affiliation:
Brésil